Gene · 79679
Papers2,409
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,161 to 1,180 of 2,409
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The integration of differentially expressed genes based on multiple microarray datasets for prediction of the prognosis in oral squamous cell carcinoma. | Bioengineered | 2021 | 34224327 | PubTator, text mining | PubMed |
| Omics Approaches to Study Formation and Function of Human Placental Syncytiotrophoblast. | Front Cell Dev Biol | 2021 | 34211975 | PubTator, text mining | PubMed |
| Macrophage Polarization States in the Tumor Microenvironment. | Int J Mol Sci | 2021 | 34209703 | PubTator, text mining | PubMed |
| Classification of Non-Small Cell Lung Cancer's Tumor Immune Micro-Environment and Strategies to Augment Its Response to Immune Checkpoint Blockade. | Cancers (Basel) | 2021 | 34208113 | PubTator, text mining | PubMed |
| Soluble Programmed Death Ligand-1 (sPD-L1): A Pool of Circulating Proteins Implicated in Health and Diseases. | Cancers (Basel) | 2021 | 34204509 | PubTator, text mining | PubMed |
| Immune signature-based hepatocellular carcinoma subtypes may provide novel insights into therapy and prognosis predictions. | Cancer Cell Int | 2021 | 34193146 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Prognostic Value of MEX3A and Its Relationship with Immune Infiltrates in Ovarian Cancer. | J Immunol Res | 2021 | 34189143 | PubTator, text mining | PubMed |
| A Comprehensive Prognostic and Immunological Analysis of a New Three-Gene Signature in Hepatocellular Carcinoma. | Stem Cells Int | 2021 | 34188686 | PubTator, text mining | PubMed |
| Human Endogenous Retrovirus-H Long Terminal Repeat- Associating Protein 2 (HHLA2) is a Novel Immune Checkpoint Protein in Lung Cancer which Predicts Survival. | Asian Pac J Cancer Prev | 2021 | 34181347 | PubTator, text mining | PubMed |
| Perspectives on Immunotherapy of Metastatic Colorectal Cancer. | Front Oncol | 2021 | 34178645 | PubTator, text mining | PubMed |
| Dexamethasone suppresses immune evasion by inducing GR/STAT3 mediated downregulation of PD-L1 and IDO1 pathways. | Oncogene | 2021 | 34175886 | PubTator, text mining | PubMed |
| Optimizing palliative chemotherapy for advanced invasive mucinous adenocarcinoma of the lung. | BMC Cancer | 2021 | 34174841 | PubTator, text mining | PubMed |
| The Role of B and T Lymphocyte Attenuator in Respiratory System Diseases. | Front Immunol | 2021 | 34163466 | PubTator, text mining | PubMed |
| Identification of an immune checkpoint gene signature that accurately predicts prognosis and immunotherapy response in endometrial carcinoma. | Aging (Albany NY) | 2021 | 34158412 | PubTator, text mining | PubMed |
| Identification of Tumor Microenvironment-Related Prognostic Biomarkers for Ovarian Serous Cancer 3-Year Mortality Using Targeted Maximum Likelihood Estimation: A TCGA Data Mining Study. | Front Genet | 2021 | 34149794 | PubTator, text mining | PubMed |
| The Immunology of Hormone Receptor Positive Breast Cancer. | Front Immunol | 2021 | 34135901 | PubTator, text mining | PubMed |
| Immunotherapy in endometrial cancer: rationale, practice and perspectives. | Biomark Res | 2021 | 34134781 | PubTator, text mining | PubMed |
| Adipogenesis in triple-negative breast cancer is associated with unfavorable tumor immune microenvironment and with worse survival. | Sci Rep | 2021 | 34131208 | PubTator, text mining | PubMed |
| The Prognostic Potential of Human Prostate Cancer-Associated Macrophage Subtypes as Revealed by Single-Cell Transcriptomics. | Mol Cancer Res | 2021 | 34131070 | PubTator, text mining | PubMed |
| Comprehensive Profiling Reveals Distinct Microenvironment and Metabolism Characterization of Lung Adenocarcinoma. | Front Genet | 2021 | 34122500 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79679/papers?page=59